Large-Scale Production of Vibrio cholerae Toxin B Subunit for Use in Oral Vaccines

No abstract is available for this paper.

• Publication year

  1993

• Venue

  Bio/Technology

• Publication date

  1993-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/NBT1293-1574PMID 7764248
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Large outbreak of clinical cholera due to Vibrio cholerae non-O1 in Bangladesh.

  1993cited by this paper
• Emergence of novel strain of Vibrio cholerae with epidemic potential in southern and eastern India.

  1993cited by this paper
• Large outbreak of clinical cholera due to Vibrio cholerae non-01 in Bangladesh

  1993cited by this paper
• Structure and function of cholera toxin and the related Escherichia coli heat-labile enterotoxin.

  1992cited by this paper
• An oral B subunit: whole cell vaccine against cholera.

  1992cited by this paper
• Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coli

  1991cited by this paper
• Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine.

  1991cited by this paper
• Recombinant system for overexpression of cholera toxin B subunit in Vibrio cholerae as a basis for vaccine development.

  1989cited by this paper
• Coordinated assembly of multisubunit proteins: oligomerization of bacterial enterotoxins in vivo and in vitro.

  1988cited by this paper
• Volunteer studies of deletion mutants of Vibrio cholerae O1 prepared by recombinant techniques

  1988cited by this paper
• Cross-protection by B subunit-whole cell cholera vaccine against diarrhea associated with heat-labile toxin-producing enterotoxigenic Escherichia coli: results of a large-scale field trial.

  1988cited by this paper
• Field trial of oral cholera vaccines in Bangladesh.

  1986cited by this paper
• Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors.

  1985cited by this paper
• Regulation of ribosomal RNA promoters with a synthetic lac operator.

  1984cited by this paper
• A Recombinant Live Oral Cholera Vaccine

  1984cited by this paper
• Environmental and human isolates of Vibrio cholerae and Vibrio parahaemolyticus produce a Shigella dysenteriae 1 (Shiga)-like cytotoxin.

  1984cited by this paper
• Cholera and the immune response.

  1983cited by this paper
• Receptor-specific large-scale purification of cholera toxin on silica beads derivatized with lysoGM1 ganglioside.

  1981cited by this paper
• Actions of cholera toxin and the prevention and treatment of cholera

  1981cited by this paper
• Transcription antitermination by bacteriophage lambda N gene product.

  1980cited by this paper
• Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoid

  1976cited by this paper
• A complementation analysis of the restriction and modification of DNA in Escherichia coli.

  1969cited by this paper
• Pathogenesis of experimental cholera: biologic ativities of purified procholeragen A.

  1966cited by this paper
• Immunochemical quantitation of antigens by single radial immunodiffusion.

  1965cited by this paper

• Using Vibrio natriegens for High-Yield Production of Challenging Expression Targets and for Protein Perdeuteration

  2024cites this paper
• Development of Heterologous Expression System and Optimization of the Method of Cholera Toxin β-Subunit Production in E. coli

  2023cites this paper
• A thermostable, dry formulation inactivated Hikojima whole cell/cholera toxin B subunit oral cholera vaccine.

  2023cites this paper
• Using Vibrio natriegens for high-yield production of challenging expression targets and for protein deuteration

  2023cites this paper
• Development of a heterologous expression system and optimization of the algorithm for cholera toxin β-subunit production in E. coli

  2023cites this paper
• Microbial carbohydrate-binding toxins - From etiology to biotechnological application.

  2022cites this paper
• In-Depth Characterization of a Re-Engineered Cholera Toxin Manufacturing Process Using Growth-Decoupled Production in Escherichia coli

  2022cites this paper
• An overview On Edible Vaccines: Need Of Future

  2020cites this paper
• Fucose-Galactose Polymers Inhibit Cholera Toxin Binding to Fucosylated Structures and Galactose-Dependent Intoxication of Human Enteroids

  2020cites this paper
• GM1 ganglioside-independent intoxication by Cholera toxin

  2018cites this paper
• Omics and Edible Vaccines

  2018cites this paper
• Fucosylated Molecules Competitively Interfere with Cholera Toxin Binding to Host Cells.

  2018cites this paper
• Challenges in developing mucosal vaccines and antibodies against infectious diarrhea in children

  2018cites this paper
• Surface expression of Helicobacter pylori HpaA adhesion antigen on Vibrio cholerae, enhanced by co-expressed enterotoxigenic Escherichia coli fimbrial antigens.

  2017cites this paper
• Sheet 2 of 15 US 2007 / 0212757 A 1 Pst restricted Kan gene block from puC 4 K HindIII Smal

  2017cites this paper
• Herbal Insecticides, Repellents and Biomedicines: Effectiveness and Commercialization

  2016cites this paper
• Cholera toxin B subunit pentamer reassembled from Escherichia coli inclusion bodies for use in vaccination.

  2016cites this paper
• Molecular Farming for Production of Biopharmaceuticals and Edible Vaccines in Plants

  2016cites this paper
• Construction and preclinical evaluation of mmCT, a novel mutant cholera toxin adjuvant that can be efficiently produced in genetically manipulated Vibrio cholerae.

  2016cites this paper
• Expression and functional validation of heat-labile enterotoxin B (LTB) and cholera toxin B (CTB) subunits in transgenic rice (Oryza sativa)

  2015influential citation
• Cholera Toxin B: One Subunit with Many Pharmaceutical Applications

  2015cites this paper
• B-cell epitope of beta toxin of Clostridium perfringens genetically conjugated to a carrier protein: expression, purification and characterization of the chimeric protein.

  2014cites this paper
• A Protein-Based Pentavalent Inhibitor of the Cholera Toxin B-Subunit

  2014cites this paper
• Rapid and Scalable Plant-based Production of a Cholera Toxin B Subunit Variant to Aid in Mass Vaccination against Cholera Outbreaks

  2013cites this paper
• Reengineering bacterial toxins into virus-like particles

  2013cites this paper
• Recombinant expression of in silico identified Bcell epitope of epsilon toxin of Clostridium perfringens in translational fusion with a carrier protein

  2013cites this paper
• Administration of Cholera Toxin Maturation of Gut Dendritic Cells after Oral In Vivo Adjuvant-Induced Mobilization and

  2013cites this paper
• EDIBLE VACCINE: A PROSPECTIVE SUBSTITUTE FOR BETTER IMMUNIZATION IN FUTURE

  2012cites this paper
• Receptor Binding by Cholera Toxin B-Subunit and Amino Acid Modification Improves Minimal Peptide Immunogenicity

  2012cites this paper
• Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice.

  2012cites this paper
• EDIBLE VACCINE: A BETTER WAY FOR IMMUNIZATION

  2011cites this paper
• Crystal structures exploring the origins of the broader specificity of escherichia coli heat-labile enterotoxin compared to cholera toxin.

  2010cites this paper
• Carbohydrate binding specificities and crystal structure of the cholera toxin-like B-subunit from Citrobacter freundii.

  2010cites this paper
• CD4+ T-cell responses to an oral inactivated cholera vaccine in young children in a cholera endemic country and the enhancing effect of zinc supplementation.

  2009cites this paper
• No direct binding of the heat-labile enterotoxin of Escherichia coli to E. coli lipopolysaccharides

  2009cites this paper
• Studies of Carbohydrate-Binding Proteins from Enterotoxigenic Escherichia coli

  2009cites this paper
• Vaccination against cholera and ETEC diarrhea and interventions to improve vaccine immune responses.

  2009influential citation
• Construction of non-toxic Escherichia coli and Vibrio cholerae strains expressing high and immunogenic levels of enterotoxigenic E. coli colonization factor I fimbriae.

  2008cites this paper
• Edible vaccines: A new approach to oral immunization

  2008cites this paper
• Cholera toxin B subunit promotes the induction of regulatory T cells by preventing human dendritic cell maturation

  2008cites this paper
• Novel binding site identified in a hybrid between cholera toxin and heat-labile enterotoxin: 1.9 A crystal structure reveals the details.

  2007cites this paper
• CHAPTER 12 – Molecular, functional, and evolutionary aspects of ADP-ribosylating toxins

  2006cites this paper
• CHAPTER 61 – Engineered bacterial toxin vaccines and adjuvants

  2006cites this paper
• Expression of polyhedrin-hEGF fusion protein in cultured cells and larvae of Bombyx mori

  2006cites this paper
• Construction of a non-antibiotic expression system in a marine cyanobacterium Synechococcus sp. PCC 7002 and its application in production of oral vaccine against enterotoxin of Escherichia coli

  2006cites this paper
• Cholera Toxin Induces a Transient Depletion of CD8+ Intraepithelial Lymphocytes in the Rat Small Intestine as Detected by Microarray and Immunohistochemistry

  2005cites this paper
• Lipid Rafts Activation of a Neutral Sphingomyelinase in T Cells by + and Proliferation of Human CD 4 Cholera Toxin B-Subunit Prevents Activation

  2005cites this paper
• Cholera toxin subunit B inhibits IL-12 and IFN-γ production and signaling in experimental colitis and Crohn’s disease

  2005cites this paper
• Cholera Toxin B-Subunit Prevents Activation and Proliferation of Human CD4+ T Cells by Activation of a Neutral Sphingomyelinase in Lipid Rafts1

  2005cites this paper
• Expression of cholera toxin B subunit and assembly as functional oligomers in silkworm.

  2005cites this paper
• Intranasal Immunization of Mice with Group B Streptococcal Protein Rib and Cholera Toxin B Subunit Confers Protection against Lethal Infection

  2004cites this paper
• Coupling of antigen to cholera toxin for dendritic cell vaccination promotes the induction of MHC class I‐restricted cytotoxic T cells and the rejection of a cognate antigen‐expressing model tumor

  2004cites this paper
• In Vivo Adjuvant-Induced Mobilization and Maturation of Gut Dendritic Cells after Oral Administration of Cholera Toxin1

  2004cites this paper
• Vaccination with dendritic cells pulsed in vitro with tumor antigen conjugated to cholera toxin efficiently induces specific tumoricidal CD8+ cytotoxic lymphocytes dependent on cyclic AMP activation of dendritic cells.

  2004cites this paper
• Production and Purification of Monoclonal and Polyclonal Antibodies Against Cholera Toxin

  2004cites this paper
• Transcutaneous Immunization with Cholera Toxin B Subunit Adjuvant Suppresses IgE Antibody Responses Via Selective Induction of Th1 Immune Responses 1

  2003cites this paper
• Cholera Toxin and Its B Subunit Promote Dendritic Cell Vaccination with Different Influences on Th1 and Th2 Development

  2003cites this paper
• Cholera Holotoxin Assembly Requires a Hydrophobic Domain at the A-B5 Interface: Mutational Analysis and Development of an In Vitro Assembly System

  2003influential citation
• Prevention of mucosally induced uveitis with a HSP60‐derived peptide linked to cholera toxin B subunit

  2003cites this paper
• Recombinant HpaA purified from Escherichia coli has biological properties similar to those of native Helicobacter pylori HpaA.

  2003cites this paper
• Recombinant HpaA purified from Escherichia coli has biological properties similar to those of native Helicobacter pylori HpaA

  2003cites this paper
• The role of different protein components from the Haemophilus ducreyi cytolethal distending toxin in the generation of cell toxicity.

  2001cites this paper
• Group B Streptococcus Capsular Polysaccharide-Cholera Toxin B Subunit Conjugate Vaccines Prepared by Different Methods for Intranasal Immunization

  2001cites this paper
• Cholera Toxin B Subunit as a Carrier Molecule Promotes Antigen Presentation and Increases CD40 and CD86 Expression on Antigen-Presenting Cells

  2001cites this paper
• Oral Administration of Recombinant Cholera Toxin Subunit B Inhibits IL-12-Mediated Murine Experimental (Trinitrobenzene Sulfonic Acid) Colitis1

  2001cites this paper
• Effect of pre-existing immunity for systemic and mucosal immune responses to intranasal immunization with group B Streptococcus type III capsular polysaccharide-cholera toxin B subunit conjugate.

  2001cites this paper
• Nasal Administration of Schistosoma mansoni Egg Antigen‐Cholera B Subunit Conjugate Suppresses Hepatic Granuloma Formation and Reduces Mortality in S. mansoni‐Infected Mice

  2001cites this paper
• Expression of the native cholera toxin B subunit gene and assembly as functional oligomers in transgenic tobacco chloroplasts

  2001cites this paper
• Murine Experimental (Trinitrobenzene Toxin Subunit B Inhibits IL-12-Mediated Oral Administration of Recombinant Cholera

  2001cites this paper
• Mucosal and systemic antibody responses after peroral or intranasal immunization: Effects of conjugation to enterotoxin B subunits and/or of co‐administration with free toxin as adjuvant

  2000cites this paper
• Novel Carbohydrate Binding Site Recognizing Blood Group A and B Determinants in a Hybrid of Cholera Toxin and Escherichia coli Heat-labile Enterotoxin B-subunits*

  2000cites this paper
• Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice

  2000cites this paper
• Prolonged oral treatment with low doses of allergen conjugated to cholera toxin B subunit suppresses immunoglobulin E antibody responses in sensitized mice.

  2000cites this paper
• Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy

  1999cites this paper
• Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.

  1999cites this paper
• Immunogenicity of Actinobacillus ApxIA toxin epitopes fused to the E. coli heat-labile enterotoxin B subunit.

  1999cites this paper
• Intranasal administration of a Schistosoma mansoni glutathione S-transferase-cholera toxoid conjugate vaccine evokes antiparasitic and antipathological immunity in mice.

  1999cites this paper
• Characterisation of cholera toxin by liquid chromatography--electrospray mass spectrometry.

  1999cites this paper
• Suppressive versus stimulatory effects of allergen/cholera toxoid (CTB) conjugates depending on the nature of the allergen in a murine model of type I allergy.

  1999cites this paper
• Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

  1999cites this paper
• Display of an inhibin epitope in a surface-exposed loop of the E. coli heat-labile enterotoxin B subunit.

  1998cites this paper
• Antibodies and Antibody-Secreting Cells in the Female Genital Tract after Vaginal or Intranasal Immunization with Cholera Toxin B Subunit or Conjugates

  1998cites this paper
• Affinity purification of recombinant cholera toxin B subunit oligomer expressed in Bacillus brevis for potential human use as a mucosal adjuvant.

  1998cites this paper
• Edible vaccine protects mice against Escherichia coli heat-labile enterotoxin (LT): potatoes expressing a synthetic LT-B gene.

  1998cites this paper
• Antibody responses in serum and lung to intranasal immunization with Haemophilus influenzae type b polysaccharide conjugated to cholera toxin B subunit and tetanus toxoid

  1998cites this paper
• Recombinant cholera toxin B subunit is not an effective mucosal adjuvant for oral imm_unization of mice against Helicobacter felis

  1998cites this paper
• Structural basis for differential receptor binding of cholera and Escherichia coli heat‐labile toxins: influence of heterologous amino acid substitutions in the cholera B‐subunit

  1997cites this paper
• Construction and characterization of versatile cloning vectors for efficient delivery of native foreign proteins to the periplasm of Escherichia coli.

  1997cites this paper
• A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.

  1997cites this paper
• Anticarrier immunity suppresses the antibody response to polysaccharide antigens after intranasal immunization with the polysaccharide-protein conjugate

  1997cites this paper
• Construction and Characterization of Versatile Cloning Vectors for Efficient Delivery of Native Foreign Proteins to the Periplasm ofEscherichia coli

  1997cites this paper
• Synthesis of hybrid molecules between heat-labile enterotoxin and cholera toxin B subunits: potential for use in a broad-spectrum vaccine

  1996cites this paper
• Cholera and Oral-Mucosal Anti-infectious and Anti-inflammatory Vaccines

  1996cites this paper
• Strategies for production of a potential candidate vaccine for cholera.

  1996cites this paper
• Use of Vibrio spp. for expression of Escherichia coli enterotoxin B subunit fusion proteins: purification and characterization of a chimera containing a C-terminal fragment of DNA polymerase from herpes simplex virus type 1.

  1996cites this paper
• An investigation into the high level production of proteins in tobacco using transgenic plants or viral vectors

  1996cites this paper
• Genetic detoxification of bacterial toxins.

  1996cites this paper
• Secretion of recombinant proteins by Gram-negative bacteria.

  1996cites this paper
• Identification and characterization of an extracellular protease activity produced by the marine Vibriosp 60

  1996cites this paper
• Treatment of experimental autoimmune encephalomyelitis by feeding myelin basic protein conjugated to cholera toxin B subunit.

  1996cites this paper